Aspire Private Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Aspire Private Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $1,124 - $1,326	-6 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $1,533 - $1,818	6 New	6 $2,000
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $1,198 - $1,486	-6 Closed	0 $0
Q4 2018 Feb 25, 2019	BUY	$151.91 - $192.21 $759 - $961	5 Added 500.0%	6 $1,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $151 - $192	1 New	1 $1,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspire Private Capital, LLC with notifications on news.